PPD, Inc.

Headquarters: Wilmington, NC, United States

Founded: 1985

Employees: 30,000

CEO: Mr. David S. Simmons

show_chart NASDAQ: PPD -0.15%

Market Cap

$16.58 Billion

USD as of Dec. 1, 2021

history Market Cap History

PPD, Inc. market capitalization over time

Evolution of PPD, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of PPD, Inc.

Detailed Description

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina. As of December 8, 2021, PPD, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.

Stocks & Indices

PPD, Inc. has the following listings and related stock indices.


Product & Services

Contract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include drug development, laboratory and lifecycle management.

Key People

See Senior Leadership Team page of the P P D Website


Revenue: $4.7 Billion (2020)



929 North Front Street

Wilmington, NC 28401-3331

United States

Phone: 910 251 0081